119 related articles for article (PubMed ID: 38325796)
1. Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.
Lapthorn AR; Ilg MM; Dziewulski P; Cellek S
Eur J Pharmacol; 2024 Mar; 967():176369. PubMed ID: 38325796
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars.
Lapthorn AR; Ilg MM; Sullivan JV; Dziewulski P; Cellek S
Eur J Pharmacol; 2022 Dec; 937():175374. PubMed ID: 36343693
[TBL] [Abstract][Full Text] [Related]
3. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
4. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
5. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
6. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
[TBL] [Abstract][Full Text] [Related]
7. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
8. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
10. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
11. Altered actin dynamics is possibly implicated in the inhibition of mechanical stimulation-induced dermal fibroblast differentiation into myofibroblasts.
Kuroda K; Kiya K; Matsuzaki S; Takamura H; Otani N; Tomita K; Kawai K; Fujiwara T; Nakai K; Onishi A; Katayama T; Kubo T
Exp Dermatol; 2023 Nov; 32(11):2012-2022. PubMed ID: 37724850
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition.
Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D
J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457
[TBL] [Abstract][Full Text] [Related]
13. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
[TBL] [Abstract][Full Text] [Related]
14. [Role of p38 mitogen activated protein kinase on cyclic stretch in human facial hypertrophic scar fibroblasts differentiation into myofibroblasts].
Du QC; Xiao WL; Xue LF; Wang SY; Yue J; Xu YX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Oct; 48(10):615-20. PubMed ID: 24438570
[TBL] [Abstract][Full Text] [Related]
15. Effect of Keratinocytes on Myofibroblasts in Hypertrophic Scars.
Lee JS; Kim JS; Lee JW; Choi KY; Yang JD; Cho BC; Oh EJ; Kim TJ; Ko UH; Shin JH; Jeon S; Lee YJ; Chung HY
Aesthetic Plast Surg; 2019 Oct; 43(5):1371-1380. PubMed ID: 31346713
[TBL] [Abstract][Full Text] [Related]
16. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.
Kaur H; Chaurasia SS; Agrawal V; Suto C; Wilson SE
Exp Eye Res; 2009 Aug; 89(2):152-8. PubMed ID: 19285499
[TBL] [Abstract][Full Text] [Related]
17. Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop.
Dabiri G; Tumbarello DA; Turner CE; Van de Water L
J Invest Dermatol; 2008 Oct; 128(10):2518-25. PubMed ID: 18401422
[TBL] [Abstract][Full Text] [Related]
18. AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study.
Correia-Sá IB; Carvalho CM; Serrão PV; Machado VA; Carvalho SO; Marques M; Vieira-Coelho MA
Eur J Pharmacol; 2021 Feb; 892():173738. PubMed ID: 33220269
[TBL] [Abstract][Full Text] [Related]
19. Regenerative potential of adipocytes in hypertrophic scars is mediated by myofibroblast reprogramming.
Hoerst K; van den Broek L; Sachse C; Klein O; von Fritschen U; Gibbs S; Hedtrich S
J Mol Med (Berl); 2019 Jun; 97(6):761-775. PubMed ID: 30891616
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease.
Ilg MM; Stafford SJ; Mateus M; Bustin SA; Carpenter MJ; Muneer A; Bivalacqua TJ; Ralph DJ; Cellek S
J Sex Med; 2020 Oct; 17(10):1848-1864. PubMed ID: 32771352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
